Publication | Closed Access

Phosphocreatine attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and activating TAK1 to promote myocardial survival in vivo and in vitro

Doxorubicin-induced CardiotoxicityCardiomyopathyCardiac MuscleCardiovascular DiseaseMedicinePhysiologyCardiovascular PharmacologyPharmacotherapyMyocardial SurvivalCardiovascular ToxicityPharmacologyCardiologyOxidative StressMyocardial Infarction